Skip to main content
. 2021 Feb 20;9(4):1905–1912. doi: 10.1002/ccr3.3900

FIGURE 5.

FIGURE 5

Complete response after 8 weeks of larotrectinib (200 mg/day) treatment in November 2019. No lesions with 18F‐FDG uptake were observed during the PET/CT scan. 18 F‐FDG, 2‐deoxy‐2‐[fluorine‐18] fluoro‐D‐glucose; PET/CT, positron emission tomography/computed tomography